CZDez: An oral chemotherapeutic regimen for the treatment of multiple myeloma.

被引：0
|
作者：
Moreton, P [1 ]
Morgan, GJ [1 ]
Cooke, G [1 ]
Hillmen, P [1 ]
Child, T [1 ]
机构：
[1] Gen Infirm, Acad Unit Haematol & Oncol, Leeds LS1 3EX, W Yorkshire, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4998
引用
收藏
页码：310B / 310B
页数：1
相关论文
共 50 条
  • [41] Infectious complications in multiple myeloma.
    Lightner, A
    Rosen, L
    Vescio, R
    Schiller, G
    Berenson, J
    BLOOD, 1995, 86 (10) : 741 - 741
  • [42] Amyloid arthropathy in multiple myeloma.
    Fautrel, B
    Fermand, JP
    Menkes, CJ
    Amor, B
    Dougados, M
    Ravaud, P
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 133 - 133
  • [43] Genetic Polymorphisms in multiple myeloma.
    Van Ness, B
    Griffin, S
    Zhao, F
    Oken, M
    Rue, M
    BLOOD, 2001, 98 (11) : 305B - 305B
  • [44] Early versus deferred treatment for early stage multiple myeloma.
    Djulbegovic, B
    He, YW
    Wheatley, K
    Clark, O
    Glasmacher, A
    Ross, J
    BLOOD, 2002, 100 (11) : 385B - 385B
  • [45] Local therapy of multiple myeloma. Radiotherapy and operative treatment measures
    Stahl, A.
    Belka, C.
    ONKOLOGE, 2014, 20 (03): : 257 - 260
  • [46] Treatment of bortezomib increases osteoblast function in patients with multiple myeloma.
    Heider, U
    Kaiser, M
    Müller, C
    Schulz, CO
    Jakob, C
    Zavrski, I
    Eucker, J
    Sterz, J
    Kleeberg, L
    Possinger, K
    Sezer, O
    BLOOD, 2005, 106 (11) : 965A - 965A
  • [47] Prognostic factors in multiple myeloma.: A multivariate analysis of presenting features in 394 patients with multiple myeloma.
    Turesson, I
    Abildgaard, N
    Dahl, IM
    Holmberg, E
    Hjorth, M
    Nielsen, JL
    Oden, A
    Seidel, C
    Waage, A
    Westin, J
    Wislöff, F
    BLOOD, 1998, 92 (10) : 271B - 271B
  • [48] Intermittent low doses of thalidomide in the maintenance treatment of multiple myeloma.
    Bibas, M
    Andriani, A
    Viva, F
    Gualandi, C
    Mignogna, T
    Geraldini, C
    Tarquini, D
    BLOOD, 2004, 104 (11) : 313B - 314B
  • [49] Engineering measles virus as an oncolytic agent for the treatment of multiple myeloma.
    Peng, KW
    Donovan, K
    Zhang, J
    Schneider, U
    Lust, J
    Cattaneo, R
    Russell, SJ
    BLOOD, 2000, 96 (11) : 512A - 512A
  • [50] Potential effectiveness of inhibitors of Ras signaling in the treatment of multiple myeloma.
    Reuter, CWM
    Morgan, MA
    Dolp, O
    Bergmann, L
    BLOOD, 1999, 94 (10) : 282A - 282A
12345